MedTrace Logo

Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer

NCT06046846 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-09-21

No results posted yet for this study

Summary

The overall aim of this study is to assess the feasibility of a mHealth prehabilitation programme delivered via a mobile app for people with oesophago-gastric cancer by evaluating its user satisfaction and acceptance. The research question asks what is the feasibility of a mHealth prehabilitation programme delivered via a mobile app for patients with oesophago-gastric cancer?

The primary aim of this single centred feasibility randomised controlled trial (RCT) is to explore the recruitment, adherence, and compliance of taking part in a mHealth prehabilitation programme delivered for 6 weeks via a mobile app prior to oesophago-gastric surgery. This study will develop a prehabilitation programme to investigate the feasibility and impact of delivering prehabilitation via a mobile app to patients with a diagnosis of oesophago-gastric cancer before surgery.

Conditions

  • Oesophageal Cancer
  • Gastric Cancer
  • Prehabilitation
  • mHealth Application

Interventions

DEVICE

Asensei app

The study will compare the delivery of a prehabilitation programme via a mHealth application against standard preoperative care for patients undergoing surgery for oesophago-gastric cancer

Sponsors & Collaborators

  • Royal Infirmary of Edinburgh

    collaborator OTHER

  • Queen Margaret University

    lead OTHER

Principal Investigators

  • Alison Kelly, MRes · Queen Margaret University

  • Dr Gillian Baer, PhD · Queen Margaret University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2025-01-01
Completion
2025-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046846 on ClinicalTrials.gov